Clinical trials
Terminated Peripheral Vascular Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 1 |
| 2006 | 4 |
| 2007 | 6 |
| 2008 | 3 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 4 |
| 2014 | 5 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 43 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott Medical Devices | 2 |
| FoxHollow Technologies | 2 |
| Hansen Medical | 2 |
| United Therapeutics | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Arizona Heart Institute | 1 |
| Arkansas Heart Hospital | 1 |
| AstraZeneca | 1 |
| Baker Heart and Diabetes Institute | 1 |
| Baylor Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peripheral Vascular Diseases | 43 |
| Peripheral Arterial Disease | 14 |
| Chronic Limb-Threatening Ischemia | 10 |
| Intermittent Claudication | 7 |
| Atherosclerosis | 4 |
| Cardiovascular Diseases | 4 |
| Vascular Diseases | 4 |
| Coronary Artery Disease | 3 |
| Arterial Occlusive Diseases | 2 |
| Diabetes Mellitus, Type 2 | 2 |
Trials
Showing 76 to 43 of 43. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.